Home 
Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.10, p.722–726,2020
Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.10, p.722–726,2020
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.121, No.10, p.722–726,2020 |
||
| Title: Simvastatin in an experimental spinal cord injury model: a histopathological and biochemical evidence based study | ||
| Author: T. Tascioglu, M. Karatay, Y. Erdem, A. Tekiner, H. Celik, O. Sahin, I. Sertbas, M. A. Bayar | ||
| Abstract: AIM: In this study we tried to determine the possible neuroprotective effects of simvastatin in a rat model of Spinal Cord Injury (SCI) with the help of biochemical and histopathological tests. METHODS: Rats were divided into 5 groups:1) SCI control, 2) Sham operated, 3) SCI with 10 mg/kg intraperitoneal simvastatin, 4) SCI with 10 mg/kg oral simvastatin, 5) SCI with 10 mg/kg subcutaneous simvastatin. After the treatment period, all rats were sacrificed; their blood and spinal cord samples were taken for biochemical and histopathological assessment. RESULTS: When the groups were compared in terms of oedema and inflammation status, the scores of groups receiving simvastatin were better than the control and sham groups (p = 0.001 and p = 0.038 respectively). When the 3 treatment groups (oral, intraperitoneal and subcutaneous simvastatin groups) were compared with each other in terms of inflammation, haemorrhage and oedema, there were no significant differences between groups (p = 0.112, p = 0.797 and p = 0.188, respectively). NSE and S100B levels were significantly lower in the treatment groups compared to the sham group (p = 0.039 and p = 0.004 respectively). CONCLUSION: According to our biochemical and histopathological findings, simvastatin 10 mg/kg has a positive impact in the spinal cord injury model in rats, regardless of route of application (Tab. 1, Fig. 5, Ref. 26). |
||
| Keywords: spinal cord injury, simvastatin, neuroprotective effect | ||
| Published online: 20-Sep-2020 | ||
| Year: 2020, Volume: 121, Issue: 10 | Page From: 722, Page To: 726 | |
| doi:10.4149/BLL_2020_118 |
||
|
|
 download file |
|